OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutical Sciences is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Editorial Board	341
Aerosol delivery of inhalation devices with different add-on connections to invasively ventilated COPD subjects: An in-vivo study	218
Development of cationic Isometamidium chloride loaded long-acting lipid nanoformulation: optimization, cellular uptake, pharmacokinetics, biodistribution, and immunohistochemical evaluation	126
Molecular characteristics of several drugs evaluated from solvent/water partition measurements: Solvation parameters and intramolecular hydrogen bond indicator	100
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue	97
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	91
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	75
1-MT grafted carboxymethyl chitosan and its nanoparticles: Preparation, characterization and evaluation	70
Mechanism insight on drug skin delivery from polyurethane hydrogels: Roles of molecular mobility and intermolecular interaction	64
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos	59
Development of long-acting rivastigmine drug-in-adhesive patch utilizing ion-pair strategy and characterization of controlled release mechanism	59
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies	58
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	55
Pre-miRNA-149 G-quadruplex as a molecular agent to capture nucleolin	55
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	54
Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel	53
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	52
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation	52
Impact of protein adsorption during biopharmaceutical manufacture & storage	49
In vitro identification of decreased function genetic variants of ABCB1	48
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	48
Opportunities of topical drug products in a changing dermatological landscape	47
3D printed extended-release hydrochlorothiazide tablets	46
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	46
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model	44

Evaluation of Transmission Raman spectroscopy and NIR Hyperspectral Imaging for the assessment of content uniformity in solid oral dosage forms✰	43
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	43
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	41
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	41
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	40
Microparticles and multi-unit systems for advanced drug delivery	40
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	38
Impact of Therapeutic Drug Monitoring on Microbiological Eradication in Patients with Staphylococcus Aureus Bacteremia	38
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	37
Preclinical characterization of a novel potent core protein assembly modulator for the treatment of chronic hepatitis B viral infection	36
Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study	36
UNGAP best practice for improving solubility data quality of orally administered drugs	36